More on EPRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (7/1/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Eupraxia Pharmaceuticals (NQ:EPRX)
Delayed: 7.99 +0.05 (0.63%)
Prev. Close $7.94  
Open$7.86 
52 Wk High$ 
52 Wk Low$ 
Day High$8.12 
Day Low$7.75 
P/E N/A  
EPS$ 
Volume290,313 

Friends, Peers and Foes (?): ABB, EPF, EPFCF, FLT, HCU (more...)

Mar 6, 2026 01:58 PM Form 6-K EUPRAXIA PHARMACEUTICALS For: Feb 23
Feb 23, 2026 04:35 PM Bloom Burton & Co. Starts Eupraxia Pharmaceuticals (EPRX) at Buy (1)
Feb 20, 2026 03:21 PM Form 6-K EUPRAXIA PHARMACEUTICALS For: Feb 20
Feb 20, 2026 03:11 PM Eupraxia Pharmaceuticals raises $63.2M in public offering
Feb 20, 2026 03:10 PM Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
Feb 20, 2026 06:01 AM Form SUPPL EUPRAXIA PHARMACEUTICALS
Feb 20, 2026 06:01 AM Form 6-K EUPRAXIA PHARMACEUTICALS For: Feb 19
Feb 19, 2026 04:34 PM Raymond James Resumes Eupraxia Pharmaceuticals (EPRX) at Strong Buy
Feb 19, 2026 06:05 AM Form 6-K EUPRAXIA PHARMACEUTICALS For: Feb 19
Feb 19, 2026 02:18 AM Eupraxia Pharmaceuticals prices $55 million public offering at $7 per share
View All Articles

Entities mentioned with EPRX

View All Entities